Max Estates Adjusts Quality Grade Amidst Sales Growth and EBIT Challenges
Max Estates, a midcap realty firm, has seen significant sales growth of 32.30% over five years, despite a decline in EBIT growth of 19.82%. The company maintains a moderate debt-to-EBITDA ratio and a strong equity position, positioning it competitively against peers facing greater challenges.
Max Estates, a midcap player in the realty sector, has recently undergone an evaluation revision, reflecting its current standing in the market. The company has demonstrated notable sales growth over the past five years, achieving a rate of 32.30%. However, it has faced challenges with EBIT growth, which has shown a decline of 19.82%. In terms of financial health, Max Estates maintains a debt-to-EBITDA ratio of 50.09, indicating a moderate level of leverage. The company has a net debt to equity ratio of 0.00, suggesting a strong equity position. Additionally, its average return on capital employed (ROCE) stands at 0.13%, while the return on equity (ROE) is at 1.79%.
When compared to its peers, Max Estates holds a competitive position, with several companies in the sector rated below average. Notably, firms like Sobha and Embassy Develop are currently facing more significant challenges, which may impact their market performance. Overall, the evaluation adjustment reflects the company's current operational metrics and its relative standing within the realty industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
